Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

iTeos Therapeutics (ITOS)

iTeos Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ITOS
DateTimeSourceHeadlineSymbolCompany
07/04/202421:30GlobeNewswire Inc.iTeos Presents EOS-984 Preclinical Data Demonstrating Restoration of T Cell Activity from Adenosine Suppression at the American Association for Cancer Research Annual Meeting 2024NASDAQ:ITOSiTeos Therapeutics Inc
09/03/202401:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ITOSiTeos Therapeutics Inc
09/03/202401:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ITOSiTeos Therapeutics Inc
09/03/202400:58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ITOSiTeos Therapeutics Inc
09/03/202400:57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ITOSiTeos Therapeutics Inc
08/03/202401:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ITOSiTeos Therapeutics Inc
08/03/202401:00Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ITOSiTeos Therapeutics Inc
06/03/202412:19Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ITOSiTeos Therapeutics Inc
06/03/202412:09Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ITOSiTeos Therapeutics Inc
06/03/202412:01GlobeNewswire Inc.iTeos Appoints Oncology Veteran Jill DeSimone to Its Board of DirectorsNASDAQ:ITOSiTeos Therapeutics Inc
06/03/202412:00GlobeNewswire Inc.iTeos Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdatesNASDAQ:ITOSiTeos Therapeutics Inc
05/03/202421:30GlobeNewswire Inc.iTeos to Highlight Preclinical Data on First-In-Class EOS-984 Targeting ENT1 at the American Association for Cancer Research Annual Meeting 2024NASDAQ:ITOSiTeos Therapeutics Inc
01/03/202412:00GlobeNewswire Inc.iTeos to Participate in Upcoming Investor ConferencesNASDAQ:ITOSiTeos Therapeutics Inc
10/01/202422:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ITOSiTeos Therapeutics Inc
08/01/202412:00GlobeNewswire Inc.iTeos Announces 2024 Strategic Priorities and Anticipated MilestonesNASDAQ:ITOSiTeos Therapeutics Inc
03/01/202412:00GlobeNewswire Inc.iTeos to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:ITOSiTeos Therapeutics Inc
08/12/202301:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ITOSiTeos Therapeutics Inc
08/12/202301:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ITOSiTeos Therapeutics Inc
08/12/202301:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ITOSiTeos Therapeutics Inc
08/12/202301:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ITOSiTeos Therapeutics Inc
08/12/202301:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ITOSiTeos Therapeutics Inc
08/12/202301:16Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ITOSiTeos Therapeutics Inc
07/12/202321:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ITOSiTeos Therapeutics Inc
21/11/202312:00GlobeNewswire Inc.iTeos to Present at the Piper Sandler 35th Annual Healthcare ConferenceNASDAQ:ITOSiTeos Therapeutics Inc
07/11/202312:06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ITOSiTeos Therapeutics Inc
07/11/202312:00GlobeNewswire Inc.iTeos Reports Third Quarter 2023 Financial Results and Provides Business UpdatesNASDAQ:ITOSiTeos Therapeutics Inc
12/10/202322:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ITOSiTeos Therapeutics Inc
11/10/202322:55PR Newswire (US)NCR Atleos Set to Join S&P SmallCap 600NASDAQ:ITOSiTeos Therapeutics Inc
06/09/202312:00GlobeNewswire Inc.iTeos to Participate in Upcoming Investor ConferencesNASDAQ:ITOSiTeos Therapeutics Inc
08/08/202312:02Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ITOSiTeos Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:ITOS